Stay updated on Magrolimab in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on magrolimab, while adding a new section on hematological malignancies and an updated revision number.SummaryDifference9%
- Check37 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date of January 17, 2025, has been added. However, the deletion of the date March 25, 2025, does not significantly impact the core content.SummaryDifference0.3%
- Check81 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check95 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
- Check102 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.